^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    Vartrace® AML Panel

    Company:
    NuProbe
    Type:
    Laboratory Developed Test
    Related tests:

    Details

    Evidence
    News
    Vartrace® AML Panel is a targeted qPCR-based comprehensive hematological panel that detects 254 AML hotspot mutations in 6 genes: FLT3, DNMT3A, IDH1, IDH2, KIT, and NPM1. AML sequencing research panel effectively improves Sanger’s limit of detection of 20% VAF to 0.1% VAF.
    Cancer:
    Acute Myelogenous Leukemia
    Gene:
    DNMT3A (DNA methyltransferase 1), FLT3 (Fms-related tyrosine kinase 3), IDH1 (Isocitrate dehydrogenase (NADP(+)) 1), IDH2 (Isocitrate Dehydrogenase (NADP(+)) 2), KIT (KIT proto-oncogene, receptor tyrosine kinase), NPM1 (Nucleophosmin 1)
    Method:
    PCR